ETC
ROIV icon

Exchange Traded Concepts’s Roivant Sciences ROIV Stock Holding History

Exchange Traded Concepts’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.8M Buy
276,954
+271,406
+4,892% +$8.02M 0.04% 352
2026
Q1 		$154K Sell
5,548
-244,920
-98% -$6.29M ﹤0.01% 1284
2025
Q4 		$5.44M Buy
+250,468
New +$4.94M 0.04% 395
2024
Q4 		– Sell
-196,480
Closed -$2.27M – 1457
2024
Q3 		$2.27M Buy
+196,480
New +$2.24M 0.05% 297
2023
Q4 		– Sell
-172,925
Closed -$2.02M – 1367
2023
Q3 		$2.02M Buy
+172,925
New +$1.95M 0.06% 237

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Exchange Traded Concepts's ROIV Position: Q2 2026 in Review

Exchange Traded Concepts increased its Roivant Sciences (ROIV) stake by 4,892% in Q2 2026, buying an estimated $8.02M and bringing the position to 276,954 shares worth $9.8M. The position accounts for 0.04% of the portfolio, ranked #352.

Exchange Traded Concepts first reported a position in ROIV in Q3 2023 and has held it in 5 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Exchange Traded Concepts held 276,954 shares of Roivant Sciences worth $9.8M as of Q2 2026.
  • Exchange Traded Concepts bought 271,406 Roivant Sciences shares in Q2 2026, an estimated $8.02M.
  • Roivant Sciences made up 0.04% of Exchange Traded Concepts's portfolio in Q2 2026, its #352 holding.
  • Exchange Traded Concepts first reported a position in Roivant Sciences in Q3 2023 and has held it in 5 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.